Tag: Celgene

Prothena starts collaboration with Celgene to develop new neuroscience therapies

drug development
Prothena Corporation, a biotechnology company focused on the discovery, development of therapies in the neuroscience, announced a collaboration with Celgene to develop new therapies for a range of neurodegenerative diseases.

Celgene and Vividion Therapeutics will jointly discover new medicines

Vividion Therapeutics, a biotechnology company using revolutionary proteomics and chemistry platforms, announced a strategic research collaboration with Celgene Corporation.

Celgene Corporation acquires Juno Therapeutics

Celgene Corporation and Juno Therapeutics, Inc. today announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno

Celgene will launch a new research incubator

Celgene Corporation announced its plans to open the Thomas O. Daniel Research Incubator and Collaboration Center, offering entrepreneurs lab space, resources and support to scientists and companies

Celgene announced the buyout of Impact Biomedicines

Celgene Corporation and Impact Biomedicines announced the signing of a definitive agreement in which Celgene will acquire Impact Biomedicines